Equities
DAX slips 0.5% to 25,460 as political uncertainty stalls recovery
The German DAX fell 0.5% to 25,460 points by midday, losing earlier gains and stalling at its 50‑day moving average. MDAX also slipped 0.4% to 31,400 amid mixed corporate moves and geopolitical concerns.
European Stocks Hold Steady Ahead of US-China Talks
European equity markets traded cautiously Thursday as investors awaited clarity on US-China trade tensions, with the EuroStoxx 50 down 0.17% and the Swiss SMI flat.
Swiss Market Holds Steady Amid Mixed US Openings; UBS Regulatory Loss Weighs on Blue Chips
The Swiss Market Index (SMI) held near break-even, while UBS faced losses after a Ständerat ruling on stricter capital requirements. US markets opened mixed, with Nasdaq futures unchanged but Dow Jones and S&P 500 futures rising slightly.
General Mills Beats Q1 Earnings, Shares Rise on Stronger Than Expected Results
The snack and cereal giant reported adjusted earnings per share of $0.75, exceeding forecasts, while revenue surpassed expectations at $4.4 billion.
Silvia Repurchases 2.3% of Shares at Discount to NAV
Silvia, Inc. repurchased an additional 2.3% of its common stock outstanding at a discount to net asset value (NAV), continuing its buyback program since inception.
Biomea Fusion Abandons IPO Plans Amid Market Conditions
Biomea Fusion, a clinical-stage biotech focused on diabetes and obesity therapies, suspends its $30M+ S-3 shelf registration after determining current market conditions were not favorable for a public offering.
AC Immune Reports Positive Phase 2 Data for Parkinson's Immunotherapy ACI-7104
Swiss biotech AC Immune says all 25 patients on ACI-7104 developed target antibodies in its VacSYn trial, clearing a key step toward a phase 3 decision for early-stage Parkinson's disease.
Abasca files technical report for Loki graphite deposit in Canada
Abasca has submitted a technical report regarding its Loki graphite deposit in Canada.
Schweizer SMI knapp über Gewinnzone, UBS profitiert von Ständeratsentscheid
Der Schweizer Leitindex SMI bleibt am Mittwoch knapp über der Gewinnzone, während die UBS nach strengeren Eigenkapitalvorschriften des Ständerats profitiert. 11 von 20 SMI-Titeln verzeichneten Verluste, während US-Futures und globale Risikoströmungen uneinheitlich reagierten.
NIQ launches retail proximity targeting solution for advertisers
NIQ announced the launch of a retail proximity targeting solution aimed at advertisers.
CGI partners with D-Wave to offer quantum computing services
CGI and D-Wave have announced a partnership to provide quantum computing services, according to a company news report.
AEVEX unveils Specter autonomous jet platform
AEVEX has introduced Specter, a new autonomous jet platform, according to company news coverage.
Boku Reports H1 2026 Growth, Stripe Partnership Highlights
Boku Inc. delivered 11% underlying revenue growth in H1 2026, with bundling surging 39% and a strategic Stripe partnership announced.
Garanti Bank Plans 150 Million Lira Warrant Offering
Turkish lender Garanti Bank has filed for a public issuance of 150 million Turkish lira in intermediary institution warrants, offering them to domestic investors.
Peach Property AG Posts HY 2026 Turnaround with EBITDA Up 25%
Gerald Klinck’s leadership drives revenue growth and debt reduction amid asset optimization efforts.
Schweizer SMI knapp in Gewinnzone, UBS-Regulierung bleibt zentraler Fokus
Der Schweizer Leitindex SMI bleibt am Mittwoch knapp über der Nulllinie, während die UBS nach Ständeratsentscheidung zulegen konnte. Tech-Werte dominieren die positiven Entwicklungen, während andere SMI-Titel unter Druck geraten.
Julius Bär strategist flips Galderma again; Swiss Life board sells biggest stake in years
A prominent Swiss equities strategist reversed course on SMI newcomer Galderma after being stopped out at a ~14% loss. Meanwhile, an unnamed Swiss Life supervisory-board member disclosed a ~4.7m CHF share sale.
Boku H1 2026 slides: 11% underlying revenue growth, Stripe partnership
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
André Näpflin joins Inventx’s banking leadership
Swiss fintech Inventx promotes André Näpflin to head its banking division, effective November 1, with a phased transition starting October 1.
JD Sports H1 2026 sales decline prompts stock drop as margins tighten
Organic sales fell 0.7% and operating profit dropped 19.5% year-on-year, while the company adjusted its full-year guidance amid a maturing retail market.
GSK Outlines £40B Revenue, 31% Margin Targets Amid Oncology Focus
GSK projects over £40 billion in sales by 2026, aiming for 7% annual revenue growth and a 31% EBIT margin, with oncology driving key pipeline advances and restructuring efforts.
Pollen Street Explores Strategic Options Including Going Private
Pollen Street is considering a range of strategic alternatives, among them the possibility of taking the company private.
Central Asia Metals court hearing adjourned to October 14
Finance Review Daily is tracking this developing story; further verified details were not immediately available.
Dax opens flat as political uncertainty weighs on German equities
Moderate gains from early trading failed to sustain, with oil prices offering limited support amid mixed geopolitical and domestic developments.